A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis.

MLA

Lunetta, Christian, et al. “A Phase I/IIa Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation in Amyotrophic Lateral Sclerosis.” Journal of Neurology, vol. 269, no. 10, Oct. 2022, pp. 5337–46. EBSCOhost, https://doi.org/10.1007/s00415-022-11185-w.

APA

Lunetta, C., Lizio, A., Cabona, C., Gerardi, F., Sansone, V. A., Corbo, M., Scialò, C., Angelucci, E., Gualandi, F., Marenco, P., Grillo, G., Cairoli, R., Cesana, C., Saccardi, R., Melazzini, M. G., Mancardi, G., & Caponnetto, C. (2022). A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis. Journal of Neurology, 269(10), 5337–5346. https://doi.org/10.1007/s00415-022-11185-w

Chicago

Lunetta, Christian, Andrea Lizio, Corrado Cabona, Francesca Gerardi, Valeria Ada Sansone, Massimo Corbo, Carlo Scialò, et al. 2022. “A Phase I/IIa Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation in Amyotrophic Lateral Sclerosis.” Journal of Neurology 269 (10): 5337–46. doi:10.1007/s00415-022-11185-w.